Companies: 48,687 Total Market Cap: 127290921050085.47

Fresenius Medical Care AG

ETR-FME
Healthcare Medical Care Facilities
Rank #1288
Market Cap 15.03 B
Volume 717,869.82
Price 51.21
Change (%) 1.86%
Country or region Germany Germany

Fresenius Medical Care AG's latest marketcap:

15.03 B

As of May 4, 2025, Fresenius Medical Care AG's market capitalization has reached $15.03 B. According to our data, Fresenius Medical Care AG is the 1288th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 15.03 B
Revenue (ttm) 21.84 B
Net Income (ttm) 607.58 M
Shares Out 293.41 M
EPS (ttm) 2.07
Forward PE 12.63
Ex-Dividend Date May 23, 2025
Earnings Date May 6, 2025
Market Cap Chart
Data Updated: May 4, 2025

Fresenius Medical Care AG's yearly market capitalization.

Fresenius Medical Care AG has seen its market value drop from €19.97 B to €12.35 B since 2020, representing a total decrease of 38.18% and an annual compound decline rate (CAGR) of 10.56%.
Date Market Cap Change (%)
April 22, 2025 €12.35 B -4.71%
December 30, 2024 €12.96 B 16.33%
December 29, 2023 €11.14 B 24.17%
December 30, 2022 €8.97 B -46.42%
December 30, 2021 €16.74 B -16.18%
December 30, 2020 €19.97 B

Company Profile

About Fresenius Medical Care AG

Fresenius Medical Care AG is a global leader in dialysis and renal care services, operating in Germany, the United States, and internationally. The company specializes in comprehensive treatment solutions for patients with kidney diseases.

Services Offered

  • Dialysis Treatment: Outpatient dialysis clinics, hospital-based dialysis services, and acute kidney failure care.
  • Patient Support: Clinical monitoring, follow-up assistance, and home delivery of medical supplies.
  • Specialty Care: Vascular, cardiovascular, endovascular, and nephrology services.

Product Portfolio

The company develops and manufactures a wide range of healthcare products, including:

  • Polysulfone dialyzers and hemodialysis machines
  • Peritoneal dialysis cyclers and solutions
  • Hemodialysis concentrates and bloodlines
  • Renal pharmaceuticals and water treatment systems
  • Acute cardiopulmonary and apheresis products

Distribution & Sales

Fresenius Medical Care AG supplies its products to:

  • Dialysis clinics and hospitals
  • Specialized treatment centers

Sales are conducted through local sales teams, independent distributors, and dealers.

Founded: 1996
Headquarters: Bad Homburg, Germany

Frequently Asked Questions

As of May 4, 2025, Fresenius Medical Care AG (including the parent company, if applicable) has an estimated market capitalization of $15.03 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Fresenius Medical Care AG global market capitalization ranking is approximately 1288 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Germany
Founded 1996
IPO Date n/a
Employees 111,513
CEO Helen Giza
Sector Healthcare
Industry Medical Care Facilities
Address Else-Kröner-Strasse 1
Bad Homburg, 61352
Germany
People Also Watch
HCA
347.97 1.86%
TADAWUL-4013
76.93 1.86%
ETR-FRE
47.68 1.86%
SHE-300015
1.78 1.86%